Vulvar melanoma

Specialty
Gynaecology · Vulva & vagina
Images
Histology & cytology 1 · Clinical 1
In the app
1 flashcards · GynFuchs
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (2)
  2. Definition
  3. Classification
  4. Occurrence & epidemiology
  5. Aetiopathogenesis
  6. Clinical features
  7. Diagnosis
  8. Keep learning in the app
  9. Further reading (selection)
  10. Cross-references

Images (2)

Vulvar melanoma – Histology & cytology: Histology (H&E): large, pale, vacuolated Paget cells, singly and in nests within the epidermis — Paget's disease of the vulvaHistology & cytology
Histology (H&E): large, pale, vacuolated Paget cells, singly and in nests within the epidermis — Paget's disease of the vulvaImage: Nephron (Wikimedia Commons) · CC BY-SA 3.0 · Source · cropped
Vulvar melanoma – Clinical: Vulvar carcinoma with a papillomatous, condyloma-like appearance
Vulvar carcinoma with a papillomatous, condyloma-like appearanceImage: Achdiat PA, Rianty F, Hidayah RMN, et al. / Case Rep Dermatol Med 2025 · CC BY 4.0 · Source · cropped
1 / 2

Definition

Vulvar Melanoma

  • Incidence: Vulvar melanoma is the second most common malignant tumour of the vulva.
  • Clinical presentation: Suspicious findings are newly appeared, irregularly pigmented, asymmetrical lesions with an indistinct border, bleeding, or an increase in size.
  • Location: The most common locations are the clitoral region and the labia minora, i.e., non-hair-bearing parts.
  • Prognostic factor: The decisive prognostic factor is the tumour thickness according to Breslow.
  • Vulvar melanoma is a malignant melanocytic tumour of the vulva; the vulva is the most common site of melanoma in the female genital tract.

Classification

  • The mucosal lentiginous subtype is the most common histologically; nodular and superficial spreading melanomas are also described.

Occurrence & epidemiology

Epidemiology

  • It is the second most common malignant tumour of the vulva after squamous cell carcinoma.
  • Mainly white women from the fifth to the seventh or eighth decade are affected; the mean age at diagnosis is 60–63 years.

Aetiopathogenesis

Aetiology and risk factors

  • The relationship with sun exposure is undefined.
  • KIT mutations are molecularly characteristic; BRAF and NRAS mutations also occur.

Clinical features

  • Tumours occur, in descending order of frequency, on the labia majora, labia minora and clitoral hood, mainly on hairless mucosa; only about 13 % affect the outer hair-bearing skin.
  • Symptoms are non-specific: itching, bleeding or atypical discharge and a sensation of a lump, with lymphadenopathy in advanced disease; some tumours are asymptomatic.
  • Amelanotic forms account for 2–10 % and are more common after the menopause; clinical presentation is often delayed because early symptoms are absent.

Diagnosis

  • The diagnosis is made by biopsy and confirmed by immunohistochemistry, for amelanotic lesions for example with HMB-45, S-100, MART-1 and tyrosinase.
  • Micro-staging follows Clark, Breslow and Chung; dermoscopy and confocal microscopy support the clinical assessment.

Keep learning in the app

In the GynFuchs app you can learn Vulvar melanoma with flashcards, exam questions and image tasks (colposcopy, ultrasound, CTG) – free, in your browser or as an app.

In the app: 1 flashcards on this topic

Open in browser  About GynFuchs →

Further reading (selection)

  1. Vulvar Malignant Melanoma: A Narrative Review (Cancers 2022, PubMed Central)
  2. DocCheck Flexikon, Morbus Paget

Cross-references

Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.